PSC
MNTA

Piper Sandler & Co’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Piper Sandler & Co’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$2K – 20
2018
Q1 		$2K Buy
+100
New +$1.67K ﹤0.01% 12

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Piper Sandler & Co's MNTA Position: Q2 2018 in Review

Piper Sandler & Co sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2018, closing a stake of 100 shares — an estimated $2K sold.

Piper Sandler & Co first reported a position in MNTA in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 160 funds tracked by Wall St. Rank hold MNTA as of Q2 2018.

  • Piper Sandler & Co reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Piper Sandler & Co sold 100 Momenta Pharmaceuticals, Inc. shares in Q2 2018, an estimated $2K.
  • Piper Sandler & Co first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 1 quarter.
  • Piper Sandler & Co's Momenta Pharmaceuticals, Inc. position peaked at $2K in Q1 2018.
  • 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2018.

Based on Piper Sandler & Co's 13F filing for Q2 2018, filed 13 Aug 2018.